论文部分内容阅读
[目的]观察参苏理肺丸联合西药治疗慢性阻塞性肺病疗效。[方法]使用随机平行对照方法,将64例住院患者按抽签法随机分为两组。对照组32例持续低流量吸氧,抗感染,保持呼吸道通畅,解痉、平喘、祛痰,降低肺动脉压,强心利尿,对症支持等综合治疗。治疗组32例参苏理肺丸,12g/次,2次/d;西药治疗同对照组。连续治疗14d为1疗程。观测临床症状、肺部病灶、痰菌、不良反应。治疗1疗程,判定疗效。[结果]治疗组痊愈14例,显效8例,有效7例,无效2例,总有效率93.75%。对照组痊愈4例,显效8例,有效12例,无效8例,总有效率75.00%。治疗组疗效优于对照组(P<0.05)。[结论]参苏理肺丸联合西药治疗慢性阻塞性肺病效果显著,值得推广。
[Objective] To observe the therapeutic effect of Shen Su Li Pill combined with western medicine on chronic obstructive pulmonary disease. [Methods] Using randomized parallel control method, 64 inpatients were randomly divided into two groups according to random selection. The control group, 32 cases of continuous low-flow oxygen, anti-infection, maintain airway patency, antispasmodic, antiasthmatic, expectorant, reduce pulmonary artery pressure, cardiac diuretic, symptomatic support and other comprehensive treatment. Treatment group, 32 cases of Su-lung pills, 12g / times, 2 times / d; Western medicine treatment with the control group. Continuous treatment 14d for a course of treatment. Observation of clinical symptoms, lung lesions, sputum bacteria, adverse reactions. Treatment of a course of treatment to determine the efficacy. [Results] The treatment group cured 14 cases, 8 cases markedly effective in 7 cases, 2 cases, the total effective rate 93.75%. In the control group, 4 cases were cured, 8 cases were markedly effective, 12 cases were effective, 8 cases were ineffective, and the total effective rate was 75.00%. The treatment group was better than the control group (P <0.05). [Conclusion] Shen Su Li Pills combined with Western medicine in treating chronic obstructive pulmonary disease has remarkable effect and is worth popularizing.